Emergence of SARS-CoV-2 Variants and Impact on IVD Testing - Emergence of SARS-CoV-2 Variants and Impact on IVD Testing - POCTRN

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

Learn More >>

Tartalom megjelenítő

angle-left Emergence of SARS-CoV-2 Variants and Impact on IVD Testing

Emergence of SARS-CoV-2 Variants and Impact on IVD Testing


Speakers: 
Richard Creager, PhD
Co-Founder & Partner, NaviDx LLC

Eric Lai, PhD 
Ex-SVP at Takeda Pharmaceutical and Head of R&D at Gen-Probe Diagnostics

This webinar took place on March 23, 2021:

Watch the Recording >

Download the Slides >